Wordt geladen...
What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?
The introduction of imatinib to clinical practice revolutionized therapy of advanced gastrointestinal stromal tumors (GIST), but its long-term results have been only just collected. We have attempted to identify factors related to the long-term survival. We have analyzed the data of 430 inoperable/m...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Springer US
2013
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3840282/ https://ncbi.nlm.nih.gov/pubmed/24217870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-013-0765-7 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|